| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
inquiry@bocsci.com |
|
| | 5,6-Dci-cbimf sodium salt Basic information |
| Product Name: | 5,6-Dci-cbimf sodium salt | | Synonyms: | CDRBMP SODIUM SALT;5,6-DICHLORO-1-BETA-D-RIBOFURANOSYLBENZIMIDAZOLE-3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT;5,6-DCI-CBIMP, NA;5,6-Dichloro-1-B-D-ribofuranosylbenzimidazole-3'',5''-cyclic monophosphoric a;5,6-dichlorobenzimidazoleriboside-3’,5’-cyclicmonophosphate(5,6-dcl-cbimp),sodium;1H-Benzimidazole, 5,6-dichloro-1-(3,5-O-phosphinico-β-D-ribofuranosyl)-;5,6-DCl-cBIMP;5,6-Dci-cbimf sodium salt | | CAS: | 129693-10-3 | | MF: | C12H11Cl2N2O6P | | MW: | 381.11 | | EINECS: | | | Product Categories: | | | Mol File: | 129693-10-3.mol |  |
| | 5,6-Dci-cbimf sodium salt Chemical Properties |
| Boiling point | 639.3±65.0 °C(Predicted) | | density | 2.14±0.1 g/cm3(Predicted) | | pka | 0.99±0.60(Predicted) |
| | 5,6-Dci-cbimf sodium salt Usage And Synthesis |
| Uses | 5,6-DCl-cBIMP, a cyclic adenosine monophosphate analog, can act as an agonist of PDE2 and significantly enhance the cAMP and cGMP hydrolytic activities of PDE2[1][2]. | | References | [1] McMartin L, et al. Functional analysis of desensitization of the β‐adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion[J]. British journal of pharmacology, 1999, 127(4): 1012-1020. DOI:10.1038/sj.bjp.0702618
[2] Jger R, et al. Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5[J]. British journal of pharmacology, 2010, 161(7): 1645-1660. DOI:10.1111/j.1476-5381.2010.00977.x |
| | 5,6-Dci-cbimf sodium salt Preparation Products And Raw materials |
|